Short or avoid FGL. The amended toxic financing ensures relentless dilution at declining prices — every conversion pulls the stock lower, enabling larger conversions. Monitor for Nasdaq compliance risk as the share price deteriorates.
Price Chart
Executive Summary
Founder Group amended two toxic financing instruments with Streeterville Capital ($16.07M convertible note) and Avondale Capital ($1.08M pre-paid purchase), resetting conversion/purchase prices to 85% of the lowest 10-day VWAP or lowest intraday hourly VWAP. This deepens the existing dilution mechanism, allowing holders to convert at increasingly punitive discounts as the stock declines, creating a self-reinforcing downward spiral. The amendments, which provided no new cash to the company, signal acute financial distress and will likely accelerate share price erosion.
Key Facts
- Founder Group amended a $16,070,000 convertible note with Streeterville Capital and a $1,080,000 pre-paid purchase with Avondale Capital on August 19, 2026.
- The conversion/purchase price was reset to the lower of 85% of the lowest 10-day VWAP or 85% of the lowest intraday hourly VWAP.
- No new cash or consideration was provided to the company in exchange for these amendments.
- The amendments make conversion cheaper as the stock price falls, creating a classic 'death spiral' financing structure.
- The company had 29,033,700 Class A shares outstanding as of December 31, 2025, per the 20-F cross-filing.
Financial Impact
The $16.07M convertible note and $1.08M pre-paid purchase now convert at 85% of the lowest VWAP, ensuring massive dilution at progressively lower prices. No new capital was raised.
Risk Factors
- Potential short squeeze if the stock rallies unexpectedly
- Risk of reverse stock split or other anti-dilutive measures
- Possibility of a going-private transaction or restructuring that extinguishes equity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-093726 |
| Document: 0001213900-26-093726-index-headers.html | 0001213900-26-093726 |
| Document: 0001213900-26-093726-index.html | 0001213900-26-093726 |
| Document: 0001213900-26-093726.txt | 0001213900-26-093726 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 6-K | $3.45 | awaiting T+20 | — | $1.68 (−51.30%) |
Sep 21, 2026 5w ago | Press Release | $4.07 $2.42 | ▲ +40.66% | ▲ +39.76% | $1.68 (+58.72%) |
Sep 4, 2026 7w ago | 6-K | $9.30 $4.14 | ▲ +55.48% | ▲ +56.09% | $1.68 (+81.94%) |
Aug 26, 2026 8w ago | 6-K | $19.22 $4.07 | ▲ +78.82% | ▲ +80.03% | $1.68 (+91.26%) |
Jul 13, 2026 15w ago | 6-K | $1.29 $0.7950 | ▼ −38.37% | ▼ −41.56% | $1.68 (+30.23%) |
Jul 6, 2026 15w ago | 6-K | $1.41 $0.8610 | ▲ +38.94% | ▲ +42.10% | $1.68 (−19.15%) |
May 27, 2026 21w ago | EFFECT | $2.64 $1.43 | ▲ +45.83% | ▲ +43.93% | $1.68 (+36.36%) |
Mar 25, 2026 30w ago | Press Release | $3.63 $1.81 | ▼ −50.14% | ▼ −58.00% | $1.68 (−53.72%) |
Mar 16, 2026 32w ago | Press Release | $4.21 $1.71 | ▼ −59.38% | ▼ −63.16% | $1.68 (−60.10%) |
Mar 9, 2026 33w ago | EFFECT | $7.06 $2.51 | ▼ −64.45% | ▼ −61.64% | $1.68 (−76.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers